Lloyds Engg reports its Q4 results

👉Net Profit Down 19% at ₹17 Cr Vs ₹21 Cr (YoY)

👉Revenue Down 5.1% at ₹179 Cr Vs ₹188 Cr (YoY)

👉EBITDA Flat at ₹26.80 Cr (YoY)

👉Margin at 15% Vs 14.3% (YoY)

Sapphire Foods India reports #Q4 earnings

Net Profit Down 25% At ₹2 Cr Vs ₹2.40 Cr (YoY)

Revenue Up 12.60% At ₹711 Cr Vs ₹631.6 Cr (YoY)

EBITDA Down 5.2% At ₹106 Cr Vs ₹112 Cr (YoY)

Margin At 15% Vs 17.7% (YoY)

No relief for #Gensol in appeal against SEBI order.

CraftsmanAuto reports #Q4 earnings

--Net Profit Up 8% At ₹67 Cr Vs ₹62 Cr (YoY)

--Revenue Up 58.3% At ₹1,749 Cr Vs ₹1,105.3 Cr (YoY)

--EBITDA Up 17.80% At ₹244 Cr Vs ₹207 Cr (YoY)

--Margin At 14% Vs 18.7% (YoY)

Wonderla reports #Q4 earnings

👉Net Profit Down 51% At ₹11 Cr Vs ₹22.6 Cr (YoY)

👉Revenue Down 3% At ₹97 Cr Vs ₹100 Cr (YoY)

👉EBITDA Down 45% At ₹19.70 Cr Vs ₹35.80 Cr (YoY)

👉Margin At 20.3% Vs 36% (YoY)

#PNB reports its #Q4 earnings. Board approves fund raise of up to ₹8,000 cr via issuance of Basel III compliant bonds

--Net Profit Up 52% At ₹4,567 Cr Vs ₹3,010 Cr (YoY)

--NII Up 3.8% At ₹10,757 Cr Vs ₹10,363 Cr (YoY)

--Other Income At ₹4,716 CrVs ₹4,248 Cr (YoY)

--Gross NPA At 3.85% Vs 4.09% (QoQ)

--Net NPA At 0.40% Vs 0.41% (QoQ)

#RattanIndia reports its #Q4 earnings

👉Net Profit Down 99%At ₹126 Cr Vs ₹10,666 Cr (YoY)

👉One-time Gain At Nil Vs₹10,635.08 Cr (YoY)

👉Revenue Up 2.4% At ₹936 Cr Vs ₹914 Cr (YoY)

👉EBITDA Up 2.5% At ₹212 Cr Vs ₹207 Cr (YoY)

👉Margin Flat At 22.6% (YoY)

Here is the list of airports shut down after #OperationSindoor so far.

PNB reports its #Q4 earnings

Slippages at ₹3,001 cr vs ₹1,774 cr (QoQ)

Write-offs at ₹2,129 cr vs ₹1,969 cr (QoQ)

APL Apollo reports its Q4 results

👉Net Profit Up 72% at ₹293 Cr Vs ₹170.4 Cr (YoY)

👉Revenue Up 15.6% at ₹5,509 Cr Vs ₹4,765.7 Cr (YoY)

👉EBITDA Up 47.5% at ₹413.5 Cr Vs ₹280.3 Cr (YoY)

👉Margin At 7.5% VS 5.9% (YoY)

👉Board approves capex of ₹1,500 Cr for capacity enhancement from 4.5 MT to 6.8 MT

👉Recommends Final Dividend of ₹5.75/Sh

#JustIn | #PNB FY26 Guidance

Operating profit growth seen at 8-9% vs 10-12% YoY

Credit cost to be below 0.5% in FY26 vs 0.19% in FY25

#JustIn | #BPCL awards contracts for One 50 MW Windfarm Project to Suzlon Energy

#JustIn | Navin Fluorine announces strategic agreement with Chemours Company to manufacture and establish initial capacity of Opteon two-phase immersion cooling fluid – proprietary product of Chemours at company’s Surat facilities

Market breadth skewed in the favour of sellers.

Here are the top movers on #Nifty50.

Dabur India reports Q4; checkout the numbers

#RelianceJio adds 21.7 lakh mobile users in March.

Blue Star Q4: PAT up 21.5% YoY, revenue rises 20.8%

👉Recommends Final Dividend Of ₹9/Sh

Lupin launches Eslicarbazepine Acetate Tablets in the United States following US FDA approval for its Abbreviated New Drug Application (ANDA)

- Alert: Eslicarbazepine Acetate Is Used To Treat Epilepsy (Fits